Tru Shrimp names Chitogen as first large-scale chitosan buyer

Tru Shrimp's headquarters in the U.S. state of Minnesota.

Plymouth, Minnesota, U.S.A.-based medical manufacturing company Chitogen Inc. has signed a letter of intent with Balaton, Minnesota-based Trū Shrimp to purchase commercial quantities of chitosan produced from the ground-up exoskeletons of its farm-raised shrimp.

Tru Shrimp President and CEO Michael Ziebell told SeafoodSource in October 2022 his company's entrance into the chitosan market represents an important growth avenue for the start-up, which operates a pilot facility in Minnesota and which is seeking to build a large-scale land-based shrimp farm in the U.S. state of South DakotaIn August 2022, Tru Shrimp announced it had commenced production of a branded line of premium chitosan for topical and internal medical, pharmaceutical, and cosmetic applications ... 

Photo courtesy of Tru Shrimp


SeafoodSource Premium

Become a Premium member to unlock the rest of this article.

Become a member ›Already a member? Log In ›

Subscribe

Want seafood news sent to your inbox?

You may unsubscribe from our mailing list at any time. Diversified Communications | 121 Free Street, Portland, ME 04101 | +1 207-842-5500
None